Literature DB >> 22263102

Lung cancer, thyroid cancer or both: An unusual case presentation.

Costantine Albany1, Amit Jain, Thomas M Ulbright, Lawrence H Einhorn.   

Abstract

Cancer metastasis to the thyroid is rare. Primary sites that have been reported to metastasize to the thyroid gland include breast and kidney. There are very few case reports describing metastasis of a lung primary cancer to the thyroid gland. We describe a case of a never-smoker patient with metastatic adenocarcinoma of the lung and a malignant thyroid mass presenting simultaneously. The thyroid biopsy could not distinguish whether it was a metastasis or incidentally found thyroid primary carcinoma. Based on EGFR mutational status it was determined that he has a primary lung cancer and thyroid metastasis. He was started on erlotinib and has had a marked response in both the lung and the thyroid masses. The presence of mutations within the EGFR gene can help distinguish lung adenocarcinoma from other carcinomas like thyroid cancer. This is the first published case of primary lung adenocarcinoma with metastasis to thyroid and with EGFR mutation.

Entities:  

Keywords:  EGFR; Erlotinib; L858R EGFR mutation; lung adenocarcinoma; lung cancer; non-small cell lung cancer; thyroid adenocarcinoma; thyroid cancer; thyroid nodule

Year:  2011        PMID: 22263102      PMCID: PMC3256538          DOI: 10.3978/j.issn.2072-1439.2011.02.03

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  7 in total

Review 1.  Pathology of lung cancer.

Authors:  William D Travis
Journal:  Clin Chest Med       Date:  2002-03       Impact factor: 2.878

Review 2.  Current knowledge and future directions of the selective epidermal growth factor receptor inhibitors erlotinib (Tarceva) and gefitinib (Iressa).

Authors:  Wandena S Siegel-Lakhai; Jos H Beijnen; Jan H M Schellens
Journal:  Oncologist       Date:  2005-09

3.  Metastatic tumors of the thyroid gland: a study of 79 cases in Chinese patients.

Authors:  K Y Lam; C Y Lo
Journal:  Arch Pathol Lab Med       Date:  1998-01       Impact factor: 5.534

4.  Metastasis to the thyroid gland. A report of 43 cases.

Authors:  M K Nakhjavani; H Gharib; J R Goellner; J A van Heerden
Journal:  Cancer       Date:  1997-02-01       Impact factor: 6.860

Review 5.  Lung cancer in never smokers: a review.

Authors:  Janakiraman Subramanian; Ramaswamy Govindan
Journal:  J Clin Oncol       Date:  2007-02-10       Impact factor: 44.544

6.  EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib.

Authors:  William Pao; Vincent Miller; Maureen Zakowski; Jennifer Doherty; Katerina Politi; Inderpal Sarkaria; Bhuvanesh Singh; Robert Heelan; Valerie Rusch; Lucinda Fulton; Elaine Mardis; Doris Kupfer; Richard Wilson; Mark Kris; Harold Varmus
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-25       Impact factor: 11.205

7.  Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib.

Authors:  Thomas J Lynch; Daphne W Bell; Raffaella Sordella; Sarada Gurubhagavatula; Ross A Okimoto; Brian W Brannigan; Patricia L Harris; Sara M Haserlat; Jeffrey G Supko; Frank G Haluska; David N Louis; David C Christiani; Jeff Settleman; Daniel A Haber
Journal:  N Engl J Med       Date:  2004-04-29       Impact factor: 91.245

  7 in total
  9 in total

1.  Diagnosis and Treatment of Metastases to the Thyroid Gland: a Meta-Analysis.

Authors:  Patrizia Straccia; Claudia Mosseri; Chiara Brunelli; Esther Diana Rossi; Celestino Pio Lombardi; Alfredo Pontecorvi; Guido Fadda
Journal:  Endocr Pathol       Date:  2017-06       Impact factor: 3.943

2.  Pitfall in immunohistochemical staining for thyroglobulin in case of thyroid metastasis from lung carcinoma.

Authors:  Napatt Kanjanahattakij; Palapong Chayangsu; Wasana Kanoksil; Sasiphat Chontong; Chutintorn Sriphrapradang
Journal:  Cytojournal       Date:  2015-11-30       Impact factor: 2.091

3.  Thyroid metastasis from nonsmall cell lung cancer.

Authors:  Tariq Namad; Jiang Wang; Ralph Shipley; Nagla Abdel Karim
Journal:  Case Rep Oncol Med       Date:  2013-12-19

4.  Genomic Profiling Reveals Medullary Thyroid Cancer Misdiagnosed as Lung Cancer.

Authors:  Eva J Gordon; David Parker; Kelly Barth; Jennifer Pena; Julia A Elvin; Thomas DeLeon; Nina J Karlin
Journal:  Case Rep Oncol       Date:  2018-06-22

5.  Thyroid metastasis revealing a lung adenocarcinoma: A case report and review of the literature.

Authors:  Ihssan Elouarith; Leila Benbella; Othman Arsalan; Hadj Omar El Malki; Kaoutar Znati; Ahmed Jahid
Journal:  Int J Surg Case Rep       Date:  2022-08-18

6.  Epidermal growth factor mutation as a diagnostic and therapeutic target in metastatic poorly differentiated thyroid carcinoma: a case report and review of the literature.

Authors:  Hazel Lote; Jaishree Bhosle; Khin Thway; Kate Newbold; Mary O'Brien
Journal:  Case Rep Oncol       Date:  2014-06-18

7.  Real-time tests of multiple genome alterations take the first steps into the clinic: a learning example.

Authors:  Lorenzo Gerratana; Giovanna De Maglio; Alessandro De Pellegrin; Alessandro Follador; Karim Rihawi; Stefano Pizzolitto; Fabio Puglisi; Gianpiero Fasola
Journal:  Onco Targets Ther       Date:  2016-08-30       Impact factor: 4.147

8.  Thyroid metastasis revealing a lung adenocarcinoma.

Authors:  Ahmed Ben Saad; Saousen Cheikh Mhamed; Asma Migaou; Manel Njima; Asma Achour; Nesrine Fahem; Naceur Rouatbi; Samah Joobeur
Journal:  Respir Med Case Rep       Date:  2020-05-16

Review 9.  Clinicopathological and Molecular Features of Secondary Cancer (Metastasis) to the Thyroid and Advances in Management.

Authors:  Marie Nguyen; George He; Alfred King-Yin Lam
Journal:  Int J Mol Sci       Date:  2022-03-17       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.